Sector Update: Consumer Stocks Advance Pre-Bell Friday-March 2024-www.financetom.com

Sector Update: Consumer Stocks Advance Pre-Bell Friday

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Sector Update: Consumer Stocks Advance Pre-Bell Friday

Dec 6, 2024 6:22 AM

09:05 AM EST, 12/06/2024 (MT Newswires) -- Consumer stocks were advancing pre-bell Friday as the Consumer Staples Select Sector SPDR Fund ( XLP ) was up 0.1% and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) was 0.8% higher recently.

Lululemon athletica (LULU) shares were over 8% higher after the company reported a surge in fiscal Q3 earnings and revenue, and raised its guidance for fiscal 2024.

Ulta Beauty ( ULTA ) shares were up more than 10% after the company reported higher fiscal Q3 earnings and net sales. The company also raised its fiscal 2024 earnings per share guidance.

Petco Health & Wellness (WOOF) shares rallied past 23% after the company reported a fiscal Q3 adjusted loss that narrowed year-over-year as net sales increased during the period.

Previous page： Market Chatter: Shell Initiates Appeal Against Dutch Court Order Requiring 45% Emission Cuts by 2030 Next page： Roivant Sciences Says Study of Potential Uveitis Treatment Meets Endpoints; Launches Stock Repurchase; Shares Rise

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: Shell Initiates Appeal Against Dutch Court Order Requiring 45% Emission Cuts by 2030

Apr 2, 2024

08:33 AM EDT, 04/02/2024 (MT Newswires) -- Shell (SHEL) has initiated an appeal against a 2021 court ruling mandating a 45% reduction in its greenhouse gas emissions by 2030 arguing that the ruling obstructs its fight against climate change, Reuters reported Tuesday. Shell's lawyer Daan Lunsingh Scheurleer argued before the court that the 2021 order lacks a legal basis and...

Roivant Sciences Says Study of Potential Uveitis Treatment Meets Endpoints; Launches Stock Repurchase; Shares Rise

Apr 2, 2024

08:38 AM EDT, 04/02/2024 (MT Newswires) -- Roivant Sciences ( ROIV ) and Priovant Therapeutics said Tuesday that a phase 2 study evaluating brepocitinib in non-anterior non-infectious uveitis met its primary and secondary endpoints. In the study, 26 patients with non-infectious uveitis were given different doses of brepocitinib for 24 weeks. The study showed the drug had a failure rate...

Rivian misses production estimates as EV maker shifts to new supply chain

Apr 2, 2024

April 2 (Reuters) - Rivian Automotive ( RIVN ) missed market estimates for quarterly production on Tuesday, impacted by the electric vehicle maker's move to transition to new suppliers for fresh materials as it looks to reduce costs and improve efficiencies. The Amazon.com ( AMZN )-backed company produced 13,980 vehicles in the first quarter ended March 31, while eight analysts...

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder

Apr 2, 2024

08:31 AM EDT, 04/02/2024 (MT Newswires) -- Revive Therapeutics Ltd. ( RVVTF ) on Tuesday provided an update on its clinical study evaluating the safety and feasibility of oral psilocybin as a potential treatment for methamphetamine use disorder. The study being conducted at the University of Wisconsin-Madison, has enrolled nearly 50% of its intended study sample, with initial efficacy described...